The forecasted data for neoplasms mortality in Japan indicates a declining trend from 2024 to 2028. The standardized rate of female deaths per hundred thousand women decreases from 126.9 in 2024 to 122.5 in 2028. The year-on-year decreases are consistent, averaging around 0.9% annually. Comparatively, this reflects an improvement from the previous years, although specific numbers from 2023 are unavailable. Analyzing over the five-year period, the compound annual growth rate (CAGR) for the decline averages around -0.88% per year, indicating a continuous improvement in managing neoplasms fatalities among women.
Future trends to watch for include the implementation of advanced healthcare interventions and technologies, government health policies targeting early detection and treatment, and societal lifestyle changes emphasizing preventive care. Monitoring these factors could further accelerate the decrease in mortality rates.
